“Dose reduction of ibrutinib in chronic lymphocytic leukemia: long-term outcomes from a real-world single-center experience” (2026) Mediterranean Journal of Hematology and Infectious Diseases, 18(1), p. e2026090. doi:10.4084/MJHID.2026.090.